Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT04005716 · COMPLETED
Trial details
- NCT number
- NCT04005716
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-22
- Primary completion
- 2023-04-19
- Enrollment
- 457
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.